Adamis Pharmaceuticals (ADMP) will acquire DMK
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Why BofA says July Fed rate hike would be "unprecedented"
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Adamis Pharmaceuticals (ADMP) to Resume Trading at 4:35 p.m.
February 27, 2023 4:13 PM ESTAdamis Pharmaceuticals (NASDAQ: ADMP) to Resume Trading at 4:35 p.m.
... More